Annual Information Update

 

TIDMAZM 
 
RNS Number : 5527S 
Alizyme PLC 
20 May 2009 
 

+-------------------------------------+----------------------------------------+ 
| For Immediate Release               |                            20 May 2009 | 
+-------------------------------------+----------------------------------------+ 
 
 
ALIZYME PLC 
 
 
ANNUAL INFORMATION UPDATE 
 
 
Alizyme plc (LSE: AZM), Cambridge, UK, 20 May 2009: Alizyme Annual Information 
Update for the period from 1 July 2008 until 19 May 2009. 
 
 
Alizyme plc ("Alizyme" or the "Company") announces that, in accordance with the 
requirements of Prospectus Rule 5.2 issued by the Financial Services Authority, 
and following publication of the Annual Report on 30 April 2009, the following 
information has been published or made available to the public during the period 
from 1 July 2008 until 19 May 2009, in compliance with laws and rules dealing 
with the regulation of securities, issuers of securities and securities markets. 
 
 
For the purpose of this update, only references to the information are provided. 
Full copies of each item can be found at the locations specified below. The 
information referred to in this Annual Information Update was correct at the 
time it was published but may now be out-of-date. 
 
 
1. Announcements made via a Regulatory Information Service 
 
 
All documents listed below were published via a Regulatory Information Service 
on the dates indicated. 
 
 
Date of publication    Title 
01 July 2008                Annual Information Update 
16 July 2008                Major Interest in Shares 
24 July 2008COLAL-PREDEuropean Phase III Clinical Trial Results 
25 July 2008                Major Interest in Shares 
29 July 2008                Major Interest in Shares 
15 August 2008           Major Interest in Shares 
15 August 2008           Major Interest in Shares 
19 August 2008           Block Listing six monthly return 
29 August 2008           Interim Results 
05 September 2008      Update on Board Change 
11 September 2008Major Interest in Shares 
16 September 2008      Takeda Milestone Payment 
23 September 2008Major Interest in Shares 
26 September 2008      Major Interest in Shares 
15 October 2008          Major Interest in Shares 
19 November 2008       Interim Management Statement 
11 December 2008       Major Interest in Shares 
12 December 2008       Major Interest in Shares 
18 December 2008       Major Interest in Shares 
18 December 2008       Major Interest in Shares 
22 December 2008       Cetilistat Phase III Programme 
22 December 2008       Major Interest in Shares 
23 December 2008       Major Interest in Shares 
05 January 2009           Major Interest in Shares 
19 February 2009         Block Listing six monthly return 
16 March 2009            Notice of Preliminary Results 
23 March 2009            Board appointment and resignation 
23 March 2009            Preliminary Results 
23 April 2009               Board Changes 
30 April 2009              Annual Report and Accounts 
19 May 2009               Interim Management Statement 
19 May 2009               Major Interest in Shares 
 
 
Copies of the documents published via a Regulatory Information Service may be 
obtained from the Regulatory News Service provided by the London Stock Exchange 
(http://www.londonstockexchange.com/en-gb/pricesnews/marketnews/) and any 
related documents are available at the UK Listing Authority's Document Viewing 
Facility, Financial Services Authority, 25 The North Colonnade, Canary Wharf, 
London E14 5HS, UK. 
 
 
 
 
2. Documents filed at Companies House 
 
 
The Company has submitted filings to Companies House in relation to the 
following: 
 
 
Date of submission    Document 
02 September 2008 288b resignation of Director on 31 August 2008 
08 September 2008      288b resignation of Director on 5 September 2008 
08 September 2008      288b resignation of the Company Secretary on 5 September 
2008 
08 September 2008      288a appointment of the Company Secretary on 5 September 
2008 
17 March 2009        363a Annual Return made up to 22 February 2009 
01 April 2009288b resignation of Director on 1 April 2009 
01 April 2009     288a appointment of Director on 1 April 2009 
07 April 2009    288a appointment of Director on 1 April 2009 
26 April 2009    288a appointment of Director on 23 April 2009 
19 May 2009     Annual report and accounts for the year ended 31 December 2008 
 
 
Electronic copies of these documents can be purchased from Companies House via 
its website at www.companies-house.gov.uk, and hard copies can be obtained from 
Companies House, Crown Way, Cardiff CF14 3UZ, UK. 
 
 
 
 
3. Documents submitted to the Financial Services Authority during the period 
 
 
The Company's Annual Report and Accounts 2008 (published on 30 April 2009), 
Interim Report 2008 (published on 29 August 2008) and a letter to shareholders 
dated 23 March 2009 regarding electronic communications were submitted to the 
Financial Services Authority during the period. These documents are available at 
the UK Listing Authority's Document Viewing Facility, Financial Services 
Authority, 25 The North Colonnade, Canary Wharf, London E14 5HS, UK. 
 
 
 
 
4. Documents available through the Company's website 
 
 
Copies of the documents published via a Regulatory Information Service, the 
Company's Annual Report and Accounts 2008 (published on 30 April 2009) and 
Interim Report 2008 (published on 29 August 2008), the Interim Results 
Announcement for the six months ended 30 June 2008 (published on 29 August 2008) 
and the Preliminary Results for the year ended 31 December 2008 (published on 23 
March 2009) can be found on the Company's website at 'www.alizyme.com'. 
 
 
 
 
Copies of all documents referred to above are also available for inspection at 
the Company's registered office (Granta Park, Great Abington, Cambridge, CB21 
6GX, United Kingdom) during normal business hours or by request from the Company 
Secretary. 
 
 
 
 
For further information, please contact: 
 
 
Nick Blech, Company Secretary 
ALIZYME plc  Tel No: + 44 (0)1223 896000 
 
 
Further information on Alizyme can be found on the Company's website: 
www.alizyme.com 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 AIUGRGDUDXDGGCG